Search
Quick Filters
Clinical Trials Data
Showing 2625 of 543136 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 03/19/19
Due: 03/19/20
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 07/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/26/23
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 03/15/22
End: 06/15/23
Due: 06/15/24
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 04/10/24
End: 06/10/24
Due: 06/10/25
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 09/01/21
Due: 09/01/22
Phase: N/A
Priority: Normal
Start: 02/09/17
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 02/12/18
End: 08/20/19
Due: 08/20/20
Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 05/31/06
Due: 05/31/07
Phase: N/A
Priority: Normal
Start: 03/25/24
End: 03/25/29
Due: 03/25/30
Phase: N/A
Priority: Normal
Start: 09/01/18
End: 10/19/21
Due: 10/19/22
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 05/26/22
Due: 05/26/23
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 10/01/25
Due: 10/01/26
Phase: N/A
Priority: Normal
Start: 05/02/19
End: 02/28/21
Due: 02/28/22
Phase: N/A
Priority: Normal
Start: 02/21/22
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 10/24/20
End: 11/13/22
Due: 11/13/23
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 04/01/19
Due: 04/01/20